Читать книгу Immunology - Richard Coico - Страница 123

1 Ahmed SS, Plotkin SA, Black S, Coffman RL. (2011) Assessing the safety of adjuvanted vaccines. Sci Transl Med 3(93): 9.

2 Atassi MZ. (1977) Immunochemistry of Proteins, vols 1 and 2. New York: Plenum.

3 Benjamin DC, Berzofsky JA, East IJ, Gurd FRN, Hannum C, Leach SJ, Margoliash E, Michael JG, Miller A, Prager EM, Reichlin M, Sercarz EE, Smith‐Gill SJ, Todd PE, Wilson AC. (1984) The antigenic structure of proteins: a reappraisal. Annu Rev Immunol 2: 67.

4 Berzofsky JA, Cease KB, Cornette JL, Spouge JL, Margalit H, Berkower IJ, Good FM, Miller LH, DeLisi C. (1987) Protein antigenic structures recognized by T cells: potential applications to vaccine design. Immunol Rev 98: 9.

5 Carroll EC, Jin L, Munoz‐Wolf N, Oleszycka E, Moran HBT, Mansouri S, McEntee CP, Lambe E, Agger EM, Anderson P, Cunningham C, Herzog P, Fitzgerald KA, Bowie AG, Lavelle EC (2016) The vaccine adjuvant chitosan promotes cellular immunity via DNA sensor cGAS‐STING‐dependent induction of type I interferons. Immunity 15:597.

6 Christian RR, Mandl W, Black S, De Gregorio E. (2011) Vaccines for the twenty‐first century society. Nat Rev Immunol 11: 865.

7 Davis DR, Cohen GH. (1996) Interactions of protein antigens with antibodies. Proc Natl Acad Sci USA 93: 7.

8 Davis MM, Boniface JJ, Reich Z, Lyons D, Hampl J, Arden B, Chien Y. (1998) Ligand recognition by αβ T cell receptors. Annu Rev Immunol 16: 523.

9 Freund J, Calals J, Hosmer EP. (1937) Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil. Proc Soc Exp Biol Med 37: 509.

10 Global Advisory Committee on Vaccine Safety, June 2012. (2012) Wkly Epidemiol Rec 87(30): 281.

11 Mastelic B, Ahmed S, Egan WM, Del Giudice G, Golding H, Gust I, Neels P, Reed SG, Sheets RL, Siegrist CA, Lambert PH. (2010) Mode of action of adjuvants: implications for vaccine safety and design. Biologicals 38(5): 594.

12 Novotny J, Handschumacher H, Bruccoleri RE. (1987) Protein antigenicity: a static surface property. Immunol Today 8: 26.

13 Rothbard JB, Gefter ML. (1991) Interactions between immunogenic peptides and MHC proteins. Annu Rev Immunol 9: 527.

14 Watts C. (1997) Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 15: 821.